Genetics: Mutations in the IL1RN locus lead to autoinflammation

Nature Reviews Rheumatology

Volumn 5, Issue 9, 2009, Pages 480-482

  Gabay, Cem ^a   Palmer, Gaby ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

IL1RN PROTEIN, HUMAN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ANIMAL; AUTOIMMUNE DISEASE; CHILD; DISEASE MODEL; GENETICS; HUMAN; IMMUNOLOGY; INFLAMMATION; MOUSE; MOUSE MUTANT; MUTATION; NOTE; SIGNAL TRANSDUCTION;

ANIMALS; AUTOIMMUNE DISEASES; CHILD; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MICE; MICE, KNOCKOUT; MUTATION; SIGNAL TRANSDUCTION;

EID: 70350512821     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2009.177     Document Type: Article

References (10)

1. Aksentijevich, I. et al. An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N. Engl. J. Med. 360, 2426–2437 (2009).
2. Reddy, S. et al. An autoinflammatory disease due to homozygous deletion of the IL1RN locus. N. Engl. J. Med. 360, 2438–2444 (2009).
3. Horai, R. et al. Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J. Exp. Med. 191, 313–320 (2000).
4. Nicklin, M. J., Hughes, D. E., Barton, J. L., Ure, J. M. & Duff, G. W. Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene. J. Exp. Med. 191, 303–312 (2000).
5. Palmer, G., Talabot-Ayer, D., Kaya, G. & Gabay, C. Type i iL-1 receptor mediates iL-1 and intracellular iL-1 receptor antagonist effects in skin inflammation. J. Invest. Dermatol. 127, 1938–1946 (2007).
6. Abdollahi-Roodsaz, S. et al. Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. J. Clin. Invest. 118, 205–216 (2008).
7. Lamacchia, C., Palmer, G., Seemayer, C. A., Talabot-Ayer, D. & Gabay, C. Myeloid-cell specific interleukin-1 receptor antagonist deficiency enhances TH1 and TH17 responses and the severity of arthritis. Arthritis Rheum. (in press).
8. Martinon, F. & Tschopp, J. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 117, 561–574 (2004).
9. Hawkins P. N., Lachmann, H. J. & McDermott, M. F. interleukin-1-receptor antagonist in the Muckle–well syndrome. N. Engl. J. Med. 348, 2583–2584 (2003).
10. Lachmann, H. J. et al. Use of canakinumab in the cryopyrin-associated periodic syndrome. N. Engl. J. Med. 360, 2416–2425 (2009).